![Estela Rodriguez: So much work to do to address barriers and develop pragmatic trials](https://oncodaily.com/pub/uploads/2023/06/Dr.-Estela-Rodriguez-1-e1713808611574-1280x821.jpeg)
Estela Rodriguez: So much work to do to address barriers and develop pragmatic trials
Estela Rodriguez shared on X:
“Only 7.1% of patients with cancer participate in clinical trials- so much work to do to address barriers and develop pragmatic trials.
National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data | Journal of Clinical Oncology.”
Additional information.
Source: Estela Rodriguez/X
Estela Rodriguez is Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. She is board certified in medical oncology and hematology. She has a special interest in the early detection of lung cancer and increasing access to clinical trials. Dr. Rodriguez is known to help empower women to take charge of their own healthcare and believes in the power of mentorship.